Recent European supply chain due diligence laws, such as the Germany’s Act on Corporate Due Diligence Obligations in Supply Chains (LkSG) and EU’s Corporate Sustainability Due Diligence Directive, are now setting more perspective requirements for supply chain responsibility, says Pete Rau, vice president of solution consulting at EcoVadis, a provider of business sustainability ratings.
“We believe these new regulations are a good sign for levelling the playing field and raising everyone’s game and should apply to pharma companies as they would any other industry,” he says.
About the Author
Follow on Linkedin
More Content by EcoVadis